Literature DB >> 16014944

Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2.

Nina Ank1, Klavs Petersen, Lene Malmgaard, Søren C Mogensen, Søren R Paludan.   

Abstract

Elimination of viral infections is dependent on rapid recruitment and activation of leukocytes with antiviral activities to infected areas. Chemokines constitute a class of cytokines that have regulatory effects on leukocyte migration and activity. In this study we have studied the role of CC chemokine receptor 1 (CCR1) and CCR5 in host defense during a generalized herpes simplex virus type 2 (HSV-2) infection. Whereas both 4- and 8-week-old CCR1(-/-) mice resembled wild-type mice (C57BL/6) with respect to defense against the infection, significantly higher virus titers were seen in the livers and brains of 4-week-old CCR5(-/-) mice. At the age of 8 weeks, CCR5(-/-) were indistinguishable from wild-type mice and cleared the infection from liver and spleen. Although 4-week-old CCR5(-/-) mice were able to recruit natural killer (NK) cells to the site of infection, these cells had reduced cytotoxic activity compared to NK cells from wild-type mice. This was not due to lower production of alpha/beta interferon or interleukin-12, two well-described activators of cytotoxic activity in NK cells. We also noted that the spleens of young CCR5(-/-) mice did not increase in size during infection as did the spleens of wild-type and CCR1(-/-) mice. This observation was accompanied by impaired proliferation of CCR5(-/-) splenocytes (SCs) ex vivo. Moreover, migration of CD8(+) T cells to the liver in response to infection was impaired in CCR5(-/-) mice, and adoptive transfer of SCs from CCR5(-/-) mice infected for 6 days into newly infected wild-type mice did not improve antiviral activity in the liver, in contrast to what was seen in mice receiving immune SCs from wild-type mice. Altogether, this study shows that CCR5 plays an age-dependent role in host defense against HSV-2 by supporting both the innate and adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014944      PMCID: PMC1181601          DOI: 10.1128/JVI.79.15.9831-9841.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.

Authors:  M K Slifka; R R Pagarigan; J L Whitton
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

Review 2.  [gamma][delta] cells: a right time and a right place for a conserved third way of protection.

Authors:  A C Hayday
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Chemokines: immunology's high impact factors.

Authors:  C R Mackay
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

4.  CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells.

Authors:  J Aliberti; C Reis e Sousa; M Schito; S Hieny; T Wells; G B Huffnagle; A Sher
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

5.  THE MULTIPLICATION OF HERPES SIMPLEX VIRUS. II. THE RELATION BETWEEN PROTEIN SYNTHESIS AND THE DUPLICATION OF VIRAL DNA IN INFECTED HEP-2 CELLS.

Authors:  B ROIZMAN; P R ROANE
Journal:  Virology       Date:  1964-02       Impact factor: 3.616

6.  MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.

Authors:  J B Domachowske; C A Bonville; J L Gao; P M Murphy; A J Easton; H F Rosenberg
Journal:  Cell Immunol       Date:  2000-11-25       Impact factor: 4.868

7.  Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system.

Authors:  M T Liu; D Armstrong; T A Hamilton; T E Lane
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

8.  Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.

Authors:  T C Dawson; M A Beck; W A Kuziel; F Henderson; N Maeda
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

9.  The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.

Authors:  J B Domachowske; C A Bonville; J L Gao; P M Murphy; A J Easton; H F Rosenberg
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

10.  Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus.

Authors:  W G Glass; M T Liu; W A Kuziel; T E Lane
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

View more
  11 in total

1.  The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies.

Authors:  Jun Zhang; Eileen Rao; Marianna Dioszegi; Rama Kondru; Andre DeRosier; Eva Chan; Stephan Schwoerer; Nick Cammack; Michael Brandt; Surya Sankuratri; Changhua Ji
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

2.  Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.

Authors:  Manoj Thapa; William A Kuziel; Daniel J J Carr
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

3.  Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.

Authors:  Kumud K Singh; Michael D Hughes; Jie Chen; Kelesitse Phiri; Christine Rousseau; Louise Kuhn; Anna Coutsoudis; J Brooks Jackson; Laura A Guay; Philippa Musoke; Francis Mmiro; Richard D Semba; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

Review 4.  Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus.

Authors:  Michael W Ferenczy
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

5.  CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.

Authors:  P J Holst; C Orskov; K Qvortrup; J P Christensen; A R Thomsen
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 6.  Host genetic determinants of human immunodeficiency virus infection and disease progression in children.

Authors:  Kumud K Singh; Stephen A Spector
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

7.  The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis.

Authors:  Maximilian Larena; Matthias Regner; Mario Lobigs
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

8.  CCR5: From Natural Resistance to a New Anti-HIV Strategy.

Authors:  Lucia Lopalco
Journal:  Viruses       Date:  2010-02-05       Impact factor: 5.818

9.  CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.

Authors:  Jin Hyoung Kim; Ajit Mahadev Patil; Jin Young Choi; Seong Bum Kim; Erdenebelig Uyangaa; Ferdaus Mohd Altaf Hossain; Sang-Youel Park; John Hwa Lee; Seong Kug Eo
Journal:  J Neuroinflammation       Date:  2016-07-20       Impact factor: 8.322

10.  Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses.

Authors:  Christian K Holm; Stine H Rahbek; Hans Henrik Gad; Rasmus O Bak; Martin R Jakobsen; Zhaozaho Jiang; Anne Louise Hansen; Simon K Jensen; Chenglong Sun; Martin K Thomsen; Anders Laustsen; Camilla G Nielsen; Kasper Severinsen; Yingluo Xiong; Dara L Burdette; Veit Hornung; Robert Jan Lebbink; Mogens Duch; Katherine A Fitzgerald; Shervin Bahrami; Jakob Giehm Mikkelsen; Rune Hartmann; Søren R Paludan
Journal:  Nat Commun       Date:  2016-02-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.